- Home
- HUIZ vs OSRH Comparison
HUIZ vs OSRH Comparison
Compare HUIZ & OSRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | HUIZ | OSRH |
|---|---|---|
| Founded | 2006 | N/A |
| Country | China | United States |
| Employees | N/A | 22 |
| Industry | Specialty Insurers | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.8M | 17.9M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | HUIZ | OSRH |
|---|---|---|
| Price | $1.30 | $0.37 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $2.30 | N/A |
| AVG Volume (30 Days) | 9.8K | ★ 907.3K |
| Earning Date | 06-05-2026 | 05-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $8.58 | $9.30 |
| Revenue Next Year | $6.64 | N/A |
| P/E Ratio | $7.81 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.19 | $0.37 |
| 52 Week High | $4.16 | $1.79 |
Technical Indicators
Market Signals| Indicator | HUIZ | OSRH |
|---|---|---|
| Relative Strength Index (RSI) | 33.25 | 36.17 |
| Support Level | $1.19 | N/A |
| Resistance Level | $1.55 | $0.45 |
| Average True Range (ATR) | 0.09 | 0.03 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 14.55 | 7.37 |
Price Performance
Historical ComparisonAbout HUIZ Huize Holding Limited
Huize Holding Ltd is an independent online insurance product and service platform in China. The company distributes on its platform insurance products underwritten by the insurance companies that cooperate with the company, which the company refers to as its insurer partners, and helps them reach a large number of insurance clients. The company's platform offers a digitalized insurance purchase experience and services through various internet and mobile internet channels. The company generates revenues from the insurance brokerage fees paid by its insurer partners.
About OSRH OSR Holdings Inc.
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea. The company's pipeline products include: Vaximm, Darnatein, Woori IO, and RMC.